We have located links that may give you full text access.
Studies of rhinitis medicamentosa.
Chinese Medical Journal 1991 January
Nasal mucous membrane of patients with rhinitis medicamentosa caused by prolonged use of decongestants (privine) was studied by measurement of nasal mucus clearance time and observation of pathological changes under both optical and electron microscopes. It was found that privine destroyed the nasal cilia and mitochondria of epithelial cells, and disturbed their function so that they were damaged and dropped. Pathologically, the nasal epithelia were swollen, the arterioles dilated, and the glands proliferated. Twenty-two patients with rhinitis medicamentosa were treated by topical dexamethasone or triamcinolon in normal saline for 1-2 weeks followed by normal saline as regular nasal drops. Eight patients were treated effectively by oral ATP 20mg tid. The results were evaluated by nasal mucus clearance time measurement and rhinomanometry.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app